Manual compression versus MANTA device for access management after impella removal on the ICU

To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex...

Full description

Saved in:

Bibliographic Details
Published in:	Scientific reports Vol. 12; no. 1; pp. 14060 - 9
Main Authors:	Cuculi, Florim, Burkart, Philipp, Cioffi, Giacomo, Moccetti, Federico, Madanchi, Mehdi, Seiler, Thomas, Hess, Stefanie, Wolfrum, Mathias, Jeyarasa, Magiliny, Meier, Sonja, Kuzmiakova, Silvia, Hakimi, Maani, Seelos, Robert, Kobza, Richard, Toggweiler, Stefan, Attinger-Toller, Adrian, Bossard, Matthias
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 18.08.2022 Nature Publishing Group Nature Portfolio
Subjects:	692/308 692/308/409 692/4019/2776 Bleeding Catheters Compression Consortia Heart Hemodynamics Humanities and Social Sciences Intensive care Laboratories multidisciplinary Science Science (multidisciplinary) Ultrasonic imaging Ventricle
ISSN:	2045-2322, 2045-2322
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24–69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01–0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups ( p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications.
AbstractList	To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24–69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01–0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups (p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications. To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24–69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01–0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups ( p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications. Abstract To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24–69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01–0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups (p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications. To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24-69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01-0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups (p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications.To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24-69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01-0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups (p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications. To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24–69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01–0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups (p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications.
ArticleNumber	14060
Author	Wolfrum, Mathias Attinger-Toller, Adrian Burkart, Philipp Kuzmiakova, Silvia Seelos, Robert Moccetti, Federico Cioffi, Giacomo Cuculi, Florim Kobza, Richard Madanchi, Mehdi Meier, Sonja Jeyarasa, Magiliny Hakimi, Maani Bossard, Matthias Hess, Stefanie Toggweiler, Stefan Seiler, Thomas
Author_xml	– sequence: 1 givenname: Florim surname: Cuculi fullname: Cuculi, Florim organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 2 givenname: Philipp surname: Burkart fullname: Burkart, Philipp organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 3 givenname: Giacomo surname: Cioffi fullname: Cioffi, Giacomo organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 4 givenname: Federico surname: Moccetti fullname: Moccetti, Federico organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 5 givenname: Mehdi surname: Madanchi fullname: Madanchi, Mehdi organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 6 givenname: Thomas surname: Seiler fullname: Seiler, Thomas organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 7 givenname: Stefanie surname: Hess fullname: Hess, Stefanie organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 8 givenname: Mathias surname: Wolfrum fullname: Wolfrum, Mathias organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 9 givenname: Magiliny surname: Jeyarasa fullname: Jeyarasa, Magiliny organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital, Medical School, University of Zurich – sequence: 10 givenname: Sonja surname: Meier fullname: Meier, Sonja organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 11 givenname: Silvia surname: Kuzmiakova fullname: Kuzmiakova, Silvia organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 12 givenname: Maani surname: Hakimi fullname: Hakimi, Maani organization: Division of Vascular Surgery, Luzerner Kantonsspital – sequence: 13 givenname: Robert surname: Seelos fullname: Seelos, Robert organization: Division of Vascular Surgery, Luzerner Kantonsspital – sequence: 14 givenname: Richard surname: Kobza fullname: Kobza, Richard organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 15 givenname: Stefan surname: Toggweiler fullname: Toggweiler, Stefan organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 16 givenname: Adrian surname: Attinger-Toller fullname: Attinger-Toller, Adrian organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital – sequence: 17 givenname: Matthias surname: Bossard fullname: Bossard, Matthias email: matthias.bossard@luks.ch organization: Cardiology Division, Heart Center Lucerne, Luzerner Kantonsspital
BookMark	eNp9ks1u3CAUhVGVqknTvEBXSN104xawwbCpNBr1Z6Sk3STLCuHry8Qj20zBHqVvXyZO1SaLsAHBOR_3wnlNTsYwIiFvOfvAWak_popLowsmRME111Vx94KcCVbJQpRCnPy3PiUXKe1YHlKYiptX5LTMViEYOyM_r9w4u55CGPYRU-rCSA8Y05zo1er79Yq2eOgAqQ-ROoCsoIMb3RYHHCfq_ISRdsMe-97RiEM4ZFZGTLdIN-ubN-Sld33Ci4f5nNx8-Xy9_lZc_vi6Wa8uC5C8ngqjai4l167SrdeyRQBde18aqEQDDIR3Bpqy5bXyoDlK4LLSirfaINSI5TnZLNw2uJ3dx25w8bcNrrP3GyFurYtTBz1aLb3HWoCAusl0dIp5JZXwCjlrFM-sTwtrPzcDtpD7jK5_BH18Mna3dhsO1pRaK3MEvH8AxPBrxjTZoUtwfKERw5ysqFkuXldMZOm7J9JdmOOYn-qoKpURRlRZpRcVxJBSRG-hm9yUvyrf3_WWM3uMhF0iYXMk7H0k7F22iifWv308ayoXU8ricYvxX1XPuP4AQ1TK3Q
CitedBy_id	crossref_primary_10_1016_j_amjcard_2023_08_024 crossref_primary_10_1097_MAT_0000000000002081 crossref_primary_10_17925_HI_2022_16_2_105
Cites_doi	10.1093/eurheartj/suab002 10.1016/j.ijcard.2015.07.065 10.1016/j.ijcard.2009.08.003 10.1007/s11239-019-01837-6 10.1002/ccd.29696 10.1161/CIRCINTERVENTIONS.119.007258 10.1161/CIRCULATIONAHA.118.036614 10.1161/circulationaha.110.009449 10.1016/j.jacc.2012.09.001 10.1016/j.carrev.2021.02.013 10.1161/CIRCULATIONAHA.106.613596 10.1111/joic.12571 10.1016/j.hrtlng.2020.08.008 10.1016/j.jcin.2020.02.042 10.1111/joic.12080 10.1016/j.jacc.2020.12.054 10.1016/j.jcin.2019.06.049 10.1016/j.jcin.2016.12.277 10.1016/j.jacc.2016.10.022 10.1097/00003246-199510000-00009 10.1161/CIRCHEARTFAILURE.112.967224 10.1016/j.jvs.2015.03.040
ContentType	Journal Article
Copyright	The Author(s) 2022 The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s).
Copyright_xml	– notice: The Author(s) 2022 – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s).
DBID	C6C AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA
DOI	10.1038/s41598-022-18184-x
DatabaseName	Springer Nature OA/Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	CrossRef MEDLINE - Academic Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2045-2322
EndPage	9
ExternalDocumentID	oai_doaj_org_article_85ffe72c2c7b42bea60f6562f6e10b61 PMC9388691 10_1038_s41598_022_18184_x
GroupedDBID	0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c517t-96715518a48df85decc87ff39c42bc0c2fa9cb3d176fc81e5c154861d89ec7ee3
IEDL.DBID	DOA
ISICitedReferencesCount	3
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000841942700095&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2045-2322
IngestDate	Tue Oct 14 18:58:38 EDT 2025 Tue Nov 04 01:49:52 EST 2025 Thu Sep 04 17:45:30 EDT 2025 Tue Oct 07 07:45:38 EDT 2025 Sat Nov 29 06:26:47 EST 2025 Tue Nov 18 21:47:47 EST 2025 Fri Feb 21 02:39:26 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c517t-96715518a48df85decc87ff39c42bc0c2fa9cb3d176fc81e5c154861d89ec7ee3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://doaj.org/article/85ffe72c2c7b42bea60f6562f6e10b61
PMID	35982200
PQID	2703692924
PQPubID	2041939
PageCount	9
ParticipantIDs	doaj_primary_oai_doaj_org_article_85ffe72c2c7b42bea60f6562f6e10b61 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9388691 proquest_miscellaneous_2704868402 proquest_journals_2703692924 crossref_citationtrail_10_1038_s41598_022_18184_x crossref_primary_10_1038_s41598_022_18184_x springer_journals_10_1038_s41598_022_18184_x
PublicationCentury	2000
PublicationDate	2022-08-18
PublicationDateYYYYMMDD	2022-08-18
PublicationDate_xml	– month: 08 year: 2022 text: 2022-08-18 day: 18
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London
PublicationTitle	Scientific reports
PublicationTitleAbbrev	Sci Rep
PublicationYear	2022
Publisher	Nature Publishing Group UK Nature Publishing Group Nature Portfolio
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio
References	Moccetti (CR7) 2019; 12 Burzotta (CR5) 2015; 201 Mehran (CR11) 2011; 123 Abaunza (CR17) 2015; 62 Schrage (CR3) 2019; 139 Szem (CR14) 1995; 23 Megaly (CR21) 2022; 34 Ouweneel (CR4) 2017; 69 Succar, Sulaica, Donahue, Wanat (CR9) 2019; 48 Lauten (CR19) 2013; 6 O’Neill (CR18) 2014; 27 Kaki (CR1) 2018; 31 Balthazar (CR2) 2021; 77 Wood (CR6) 2019; 12 Freund (CR13) 2020; 13 Ferreiro (CR16) 2010; 145 Kappetein (CR10) 2012; 60 Van Mieghem (CR8) 2017; 10 Reynolds, Hochman (CR12) 2008; 117 Chehab (CR20) 2020; 49 Moccetti (CR15) 2021 Moccetti (CR22) 2021; 98 Karatolios, Hunziker, Schibilsky (CR23) 2021; 23 WW O’Neill (18184_CR18) 2014; 27 T Balthazar (18184_CR2) 2021; 77 M Abaunza (18184_CR17) 2015; 62 B Schrage (18184_CR3) 2019; 139 M Megaly (18184_CR21) 2022; 34 A Kaki (18184_CR1) 2018; 31 DM Ouweneel (18184_CR4) 2017; 69 JL Ferreiro (18184_CR16) 2010; 145 F Moccetti (18184_CR7) 2019; 12 HR Reynolds (18184_CR12) 2008; 117 DA Wood (18184_CR6) 2019; 12 F Moccetti (18184_CR15) 2021 AP Kappetein (18184_CR10) 2012; 60 F Burzotta (18184_CR5) 2015; 201 A Lauten (18184_CR19) 2013; 6 K Karatolios (18184_CR23) 2021; 23 NM Van Mieghem (18184_CR8) 2017; 10 A Freund (18184_CR13) 2020; 13 L Succar (18184_CR9) 2019; 48 R Mehran (18184_CR11) 2011; 123 F Moccetti (18184_CR22) 2021; 98 JW Szem (18184_CR14) 1995; 23 O Chehab (18184_CR20) 2020; 49
References_xml	– volume: 23 start-page: A10 year: 2021 end-page: A14 ident: CR23 article-title: Managing vascular access and closure for percutaneous mechanical circulatory support publication-title: Eur. Heart J. Suppl. doi: 10.1093/eurheartj/suab002 – volume: 201 start-page: 684 year: 2015 end-page: 691 ident: CR5 article-title: Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2015.07.065 – volume: 145 start-page: 235 year: 2010 end-page: 237 ident: CR16 article-title: Use of Impella recover LP 2.5 in elective high risk percutaneous coronary intervention publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2009.08.003 – volume: 48 start-page: 284 year: 2019 end-page: 291 ident: CR9 article-title: Management of anticoagulation with impella® percutaneous ventricular assist devices and review of new literature publication-title: J. Thromb. Thrombol. doi: 10.1007/s11239-019-01837-6 – year: 2021 ident: CR15 article-title: Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms publication-title: Catheter Cardiovasc. Interv. doi: 10.1002/ccd.29696 – volume: 12 start-page: e007258 year: 2019 ident: CR6 article-title: Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device publication-title: Circ. Cardiovasc. Interv. doi: 10.1161/CIRCINTERVENTIONS.119.007258 – volume: 139 start-page: 1249 year: 2019 end-page: 1258 ident: CR3 article-title: Impella support for acute myocardial infarction complicated by cardiogenic shock publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.036614 – volume: 123 start-page: 2736 year: 2011 end-page: 2747 ident: CR11 article-title: Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium publication-title: Circulation doi: 10.1161/circulationaha.110.009449 – volume: 98 start-page: E462 year: 2021 end-page: E465 ident: CR22 article-title: Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms publication-title: Catheter Cardiovasc. Interv. doi: 10.1002/ccd.29696 – volume: 60 start-page: 1438 year: 2012 end-page: 1454 ident: CR10 article-title: Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2012.09.001 – volume: 34 start-page: 75 year: 2022 end-page: 79 ident: CR21 article-title: Complications of the MANTA closure device: Insights from MAUDE database publication-title: Cardiovasc. Revasc. Med. doi: 10.1016/j.carrev.2021.02.013 – volume: 117 start-page: 686 year: 2008 end-page: 697 ident: CR12 article-title: Cardiogenic shock: Current concepts and improving outcomes publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.613596 – volume: 31 start-page: 969 year: 2018 end-page: 977 ident: CR1 article-title: Access and closure management of large bore femoral arterial access publication-title: J. Interv. Cardiol. doi: 10.1111/joic.12571 – volume: 49 start-page: 716 year: 2020 end-page: 723 ident: CR20 article-title: Incidence and clinical outcomes of nosocomial infections in patients presenting with STEMI complicated by cardiogenic shock in the United States publication-title: Heart Lung doi: 10.1016/j.hrtlng.2020.08.008 – volume: 13 start-page: 1182 year: 2020 end-page: 1193 ident: CR13 article-title: Frequency and impact of bleeding on outcome in patients with cardiogenic shock publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2020.02.042 – volume: 27 start-page: 1 year: 2014 end-page: 11 ident: CR18 article-title: The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: Results from the USpella Registry publication-title: J. Interv. Cardiol. doi: 10.1111/joic.12080 – volume: 77 start-page: 1243 year: 2021 end-page: 1256 ident: CR2 article-title: Managing patients with short-term mechanical circulatory support: JACC review topic of the week publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.12.054 – volume: 12 start-page: 1730 year: 2019 end-page: 1736 ident: CR7 article-title: Insights from a multidisciplinary introduction of the MANTA vascular closure device publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2019.06.049 – volume: 10 start-page: 613 year: 2017 end-page: 619 ident: CR8 article-title: Percutaneous plug-based arteriotomy closure device for large-bore access: A multicenter prospective study publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2016.12.277 – volume: 69 start-page: 278 year: 2017 end-page: 287 ident: CR4 article-title: Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2016.10.022 – volume: 23 start-page: 1660 year: 1995 end-page: 1666 ident: CR14 article-title: High-risk intrahospital transport of critically ill patients: Safety and outcome of the necessary "road trip" publication-title: Crit. Care Med. doi: 10.1097/00003246-199510000-00009 – volume: 6 start-page: 23 year: 2013 end-page: 30 ident: CR19 article-title: Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: Results of the Impella-EUROSHOCK-registry publication-title: Circ. Heart Fail. doi: 10.1161/CIRCHEARTFAILURE.112.967224 – volume: 62 start-page: 417 year: 2015 end-page: 423 ident: CR17 article-title: Incidence and prognosis of vascular complications after percutaneous placement of left ventricular assist device publication-title: J. Vasc. Surg. doi: 10.1016/j.jvs.2015.03.040 – volume: 23 start-page: 1660 year: 1995 ident: 18184_CR14 publication-title: Crit. Care Med. doi: 10.1097/00003246-199510000-00009 – volume: 201 start-page: 684 year: 2015 ident: 18184_CR5 publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2015.07.065 – volume: 48 start-page: 284 year: 2019 ident: 18184_CR9 publication-title: J. Thromb. Thrombol. doi: 10.1007/s11239-019-01837-6 – volume: 34 start-page: 75 year: 2022 ident: 18184_CR21 publication-title: Cardiovasc. Revasc. Med. doi: 10.1016/j.carrev.2021.02.013 – volume: 12 start-page: e007258 year: 2019 ident: 18184_CR6 publication-title: Circ. Cardiovasc. Interv. doi: 10.1161/CIRCINTERVENTIONS.119.007258 – volume: 23 start-page: A10 year: 2021 ident: 18184_CR23 publication-title: Eur. Heart J. Suppl. doi: 10.1093/eurheartj/suab002 – volume: 123 start-page: 2736 year: 2011 ident: 18184_CR11 publication-title: Circulation doi: 10.1161/circulationaha.110.009449 – volume: 60 start-page: 1438 year: 2012 ident: 18184_CR10 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2012.09.001 – year: 2021 ident: 18184_CR15 publication-title: Catheter Cardiovasc. Interv. doi: 10.1002/ccd.29696 – volume: 69 start-page: 278 year: 2017 ident: 18184_CR4 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2016.10.022 – volume: 62 start-page: 417 year: 2015 ident: 18184_CR17 publication-title: J. Vasc. Surg. doi: 10.1016/j.jvs.2015.03.040 – volume: 6 start-page: 23 year: 2013 ident: 18184_CR19 publication-title: Circ. Heart Fail. doi: 10.1161/CIRCHEARTFAILURE.112.967224 – volume: 139 start-page: 1249 year: 2019 ident: 18184_CR3 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.036614 – volume: 49 start-page: 716 year: 2020 ident: 18184_CR20 publication-title: Heart Lung doi: 10.1016/j.hrtlng.2020.08.008 – volume: 145 start-page: 235 year: 2010 ident: 18184_CR16 publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2009.08.003 – volume: 98 start-page: E462 year: 2021 ident: 18184_CR22 publication-title: Catheter Cardiovasc. Interv. doi: 10.1002/ccd.29696 – volume: 117 start-page: 686 year: 2008 ident: 18184_CR12 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.613596 – volume: 77 start-page: 1243 year: 2021 ident: 18184_CR2 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.12.054 – volume: 10 start-page: 613 year: 2017 ident: 18184_CR8 publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2016.12.277 – volume: 13 start-page: 1182 year: 2020 ident: 18184_CR13 publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2020.02.042 – volume: 12 start-page: 1730 year: 2019 ident: 18184_CR7 publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2019.06.049 – volume: 27 start-page: 1 year: 2014 ident: 18184_CR18 publication-title: J. Interv. Cardiol. doi: 10.1111/joic.12080 – volume: 31 start-page: 969 year: 2018 ident: 18184_CR1 publication-title: J. Interv. Cardiol. doi: 10.1111/joic.12571
SSID	ssj0000529419
Score	2.383571
Snippet	To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive... Abstract To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the...
SourceID	doaj pubmedcentral proquest crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher
StartPage	14060
SubjectTerms	692/308 692/308/409 692/4019/2776 Bleeding Catheters Compression Consortia Heart Hemodynamics Humanities and Social Sciences Intensive care Laboratories multidisciplinary Science Science (multidisciplinary) Ultrasonic imaging Ventricle
SummonAdditionalLinks	– databaseName: Science Database dbid: M2P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSFd0WgRUbiBlFjxxs7J7RUVHDYVQ-t1AuyHD9gJTZpN7tV---ZcbKpUoleeo2d2M7n8Yw9428I-eRkboNABJgIqfCw3TGwjUgd45URADnLXUw2IedzdXZWHvcHbm0fVrldE-NC7RqLZ-QHHJmiQJdz8fX8IsWsUehd7VNoPCSPwLJhGNI148fDGQt6saC9_q5MlquDFvQV3imDLoFqUyK9GumjSNs_sjVvR0recpdGLXT0_L79f0Ge9fYnnXYT5iV54OtX5EmXkfL6Nfk1M8hRSjHSvIuQrSkGbmxaOpvOT6bUeVxaKJi61MRci3Q5BNDQmHCcLpYxpIqu_LKBeUzhE2Bl0p-Hp2_I6dH3k8MfaZ-BIbUTJtdpWchI2WaEckFNHOCtZAh5aQWvbGZ5MKWtcsdkEaxifmJxB1Qwp0pvpff5Ltmpm9q_JZTZzMmsqIoqE4KzypSVEJkppeVSWmMSwrY4aNvTk2OWjL86uslzpTvsNGCnI3b6KiGfh3fOO3KOO2t_Q3iHmkisHR80q9-6l1OtJiF4yS23soIxelNkAUxeHgrPsqpgCdnbwqt7aW_1DbYJ-TgUg5yi88XUvtnEOvBnYDvNEyJHk2rUoXFJvfgTGb_LXKmihMa_bKffTeP_H_C7u_v6njzlKAjI76v2yM56tfH75LG9XC_a1YcoSf8AErom8g priority: 102 providerName: ProQuest
Title	Manual compression versus MANTA device for access management after impella removal on the ICU
URI	https://link.springer.com/article/10.1038/s41598-022-18184-x https://www.proquest.com/docview/2703692924 https://www.proquest.com/docview/2704868402 https://pubmed.ncbi.nlm.nih.gov/PMC9388691 https://doaj.org/article/85ffe72c2c7b42bea60f6562f6e10b61
Volume	12
WOSCitedRecordID	wos000841942700095&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database (ProQuest) customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7apIVeSp_UTbqo0FtrYslaSzpuQkJy2MWUBLaHImRZogtZb9lHSf99RrJ3GwfaXnKZgyVb0szIM4NG3wB8qkVuPQ8SoNyn3GG4YzCMSGvKKsNR5DSvY7EJMZnI6VSVd0p9hZywFh64ZdyRHHrvBLPMioqzypki8-iDMF84mlVt4JMJdSeYalG9mcKRulsyWS6PVmipwm0ynAwaNcnTm54lioD9PS_zfo7kvYPSaH_OXsDzznEko3bCL-GRa17B07aU5O_X8H1sArgoCSnibWprQ0LGxWZFxqPJ5YjULvwTCPqoxMQiiWS-y3whsVI4mc1jLhRZuvkCFZDgJ9A9JBcnV2_g6uz08uQ87UonpHZIxTpVhYhYa4bL2sthjYKSwvtcWeShzSzzRtkqr6kovJXUDW0IXQpaS-WscC5_C3vNonHvgFCb1SIrqqLKOGe0MqriPDNKWCaENSYBumWjth2ueChvca3j-XYudct6jazXkfX6JoHPu3d-tqga_-x9HKSz6xkQseMD1BPd6Yn-n54kcLiVre626UqzAD-GDiLjCXzcNeMGC6cmpnGLTeyDnME4mCUgejrRm1C_pZn9iFDdKpeyUDj4l632_Bn87wt-_xALPoBnLGh7gO-Vh7C3Xm7cB3hif61nq-UAHoupiFQOYP_4dFJ-HcQthHTMykAF0v3yYlx-uwVjmSBV
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VAoILb0SggJHgBFFjxxs7B4SWQtVVu6setlIvyDiODSux2bIPaP8Uv5Gxk2yVSvTWA9fEeYz9zcP2-BuA16VIjeN-BCh3Mbc43dE4jYhLygrNcchpWoZiE2I0ksfH-eEG_GnPwvi0ytYmBkNdzoxfI99mnikKfTnjH05-xr5qlN9dbUto1LDYt2e_ccq2eD_4hOP7hrHdz-OdvbipKhCbHhXLOM9EoCHTXJZO9kqUQQrn0txwVpjEMKdzU6QlFZkzktqe8VF9RkuZWyOsTfG91-A698xiPlWQHa7XdPyuGcrXnM1JUrm9QP_oz7BhF6ArlTw-7fi_UCagE9tezMy8sD0bvN7u3f-tv-7BnSa-Jv1aIe7Dhq0ewM264ubZQ_gy1J6DlfhM-joDuCI-MWW1IMP-aNwnpfWmk2AoT3SoJUmm6wQhEgqqk8k0pIyRuZ3OUE8JvgKjaDLYOXoER1ci22PYrGaVfQKEmqQUSVZkRcI5o4XOC4SIzoVhQhitI6DtuCvT0K_7KiA_VEgDSKWqsaIQKypgRZ1G8Hb9zElNPnJp648eTuuWnjg8XJjNv6nGDinZc84KZpgRBcpodZY4DOmZyyxNioxGsNXCSTXWbKHOsRTBq_VttEN-c0lXdrYKbbBnJE9YBKID4s4Pde9Uk--B0TxPpcxy_Pi7Fu7nH_-3wE8v_9eXcGtvPDxQB4PR_jO4zbwSei5juQWby_nKPocb5tdyspi_CFpM4OtVq8Ff_fWFpQ
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB6VFBAX3ohAASPBCVZZe52194BQaImISqIcWqkckOv12hCJbEoe0P41fh1j726qVKK3Hrjueh9jf_OwPZ4P4FUhEuO4HwHKXcQtTnc0TiOigrJccxxymhSBbEKMRvLoKBtvwZ_mLIxPq2xsYjDUxcz4NfIO85Wi0Jcz3nF1WsR4r__-5GfkGaT8TmtDp1FBZN-e_cbp2-LdYA_H-jVj_Y8Hu5-immEgMl0qllGWilCSTHNZONktUB4pnEsyw1luYsOczkyeFFSkzkhqu8ZH-CktZGaNsDbB916DbQzJOWvB9ngwHH9Zr_D4PTSUtj6pEyeys0Bv6U-0YYegY5U8Ot3whoE0YCPSvZineWGzNvjA_p3_uffuwu068ia9SlXuwZYt78ONiovz7AF8HWpfnZX4HPsqN7gkPmVltSDD3uigRwrrjSrBIJ_owDJJpuvUIRKo1slkGpLJyNxOZ6jBBF-B8TUZ7B4-hMMrke0RtMpZaR8DoSYuRJzmaR5zzmius5zzWGfCMCGM1m2gDQaUqQuze36QHyokCCRSVbhRiBsVcKNO2_Bm_cxJVZbk0tYfPLTWLX1J8XBhNv-magulZNc5K5hhRuQoo9Vp7DDYZy61NM5T2oadBlqqtnMLdY6rNrxc30YL5beddGlnq9AGe0bymLVBbAB644c275ST76HWeZZImWb48bcN9M8__m-Bn1z-ry_gJqJffR6M9p_CLeb10Rc5ljvQWs5X9hlcN7-Wk8X8ea3SBI6vWg_-Ahx2j-4
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Manual+compression+versus+MANTA+device+for+access+management+after+impella+removal+on+the+ICU&rft.jtitle=Scientific+reports&rft.au=Cuculi%2C+Florim&rft.au=Burkart%2C+Philipp&rft.au=Cioffi%2C+Giacomo&rft.au=Moccetti%2C+Federico&rft.date=2022-08-18&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-022-18184-x&rft.externalDocID=10_1038_s41598_022_18184_x
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon